Alice Bernard-Tessier, MD, highlights preliminary results from a phase 1 trial of gedatolisib plus darolutamide in mCRPC.
Alice Bernard-Tessier, MD
Advertisement
Articles by Alice Bernard-Tessier, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
How PSMA-PET shapes staging and recurrence workup in prostate cancer
2
European Commission approves perioperative pembrolizumab plus enfortumab vedotin for MIBC
3
FDA accepts new drug application for UGN-103 in recurrent LG-IR-NMIBC
4
Engy Habashy, MD, on the role of androgens in GSM management
5